EIF4EBP1 and Parkinson disease: Combining with the results that the main components of the key active constituent 30% EF significantly ameliorated MPTP-induced PD-like symptoms in zebrafish, our findings suggested that it might have a potential therapeutic effect by activating 4E-BP1 in the context of PD.